David Rosenbaum has a decade of experience in the conduct of Clinical Trials with practical monitoring and auditing experience in 15 countries from the Europe region.

He holds a Master's Degree in Regulations and Standards in Medicine. Currently, he is Managing Director of Rosenbaum Group a hybrid ???????? ???????? ???????? ???????? providing consultancy and CRO services to small and mid-sized biotech companies. At the moment the main focus of Rosenbaum Group is on the therapeutic indications of CNS, COVID19 Trials, stem cell therapies, and decentralized clinical trials.